KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) EPS (Weighted Average and Diluted) (2016 - 2025)

Tenet Healthcare's EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at $4.2 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 22.45% year-over-year to $4.2; the TTM value through Dec 2025 reached $15.49, down 52.1%, while the annual FY2025 figure was $15.49, 52.63% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $4.2 at Tenet Healthcare, up from $3.86 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $21.38 in Q1 2024 and bottomed at $0.36 in Q2 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is $2.3 (2021), against an average of $3.29.
  • The largest annual shift saw EPS (Weighted Average and Diluted) skyrocketed 1519.7% in 2024 before it tumbled 80.03% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $2.29 in 2021, then crashed by 56.77% to $0.99 in 2022, then surged by 132.32% to $2.3 in 2023, then skyrocketed by 49.13% to $3.43 in 2024, then increased by 22.45% to $4.2 in 2025.
  • Per Business Quant, the three most recent readings for THC's EPS (Weighted Average and Diluted) are $4.2 (Q4 2025), $3.86 (Q3 2025), and $3.16 (Q2 2025).